Keyphrases
2-dose
12%
A(H1N1)2009
13%
A(H1N1)pdm09
24%
Acute Respiratory Infection
13%
Age Groups
51%
Age-specific
15%
Australia
14%
Avian Influenza
15%
Bordetella Pertussis
13%
Clinical Characteristics
11%
Clinical Performance
11%
Clinical Predictors
11%
Confidence Interval
14%
Critical Care
11%
Cytomegalovirus
11%
Disease Burden
27%
Disease Case
16%
Disease Control
20%
Disease Outbreaks
11%
Drug Uptake
11%
Epidemiology
15%
Europe
67%
European Countries
53%
European Economic Area
28%
European Regions
25%
European Union
28%
Excess Mortality
26%
Female Subjects
11%
H3N2 Virus
18%
Healthcare Workers
12%
Herpes Zoster
11%
High Susceptibility
15%
High-risk Human Papillomavirus (HR-HPV)
11%
Hospital Admission
25%
Hospitalization
13%
Hospitalized Patients
12%
Human Respiratory Syncytial Virus (hRSV)
11%
Immunization Programs
15%
Incidence Data
15%
Influenza
68%
Influenza A
22%
Influenza A(H1N1)pdm09 Virus
13%
Influenza Activity
12%
Influenza Immunization
11%
Influenza Season
59%
Influenza Seasonality
11%
Influenza Surveillance
14%
Influenza Vaccination
17%
Influenza Vaccine Effectiveness
22%
Israel
26%
Italy
15%
Measles
26%
Measles-mumps-rubella
27%
Mumps
39%
Mumps Outbreak
13%
Mumps Vaccine
17%
National Immunization Technical Advisory Group (NITAG)
11%
Neospora Caninum
11%
Netherlands
25%
Older Adults
16%
Online Monitoring System
11%
Pertussis
11%
Post-pandemic
22%
Pre-pandemic
11%
Pre-vaccination
11%
Public Health Surveillance
13%
Reproduction number
11%
Respiratory Mortality
11%
Respiratory Syncytial Virus
60%
Rotavirus
17%
Rotavirus Vaccine
14%
Rubella
33%
Seasonal Influenza
28%
Sentinel System
13%
Seroepidemiology
100%
Serologic
11%
Seropositivity
14%
Seroprevalence
22%
Serosurvey
28%
Serum Samples
18%
Severe Influenza
16%
Social Contact Data
11%
Spatiotemporal Analysis
11%
Surveillance System
21%
Susceptibility Level
13%
Sweden
15%
Titre
18%
Travellers
22%
United Kingdom
20%
Vaccination
27%
Vaccination Coverage
23%
Vaccine Effectiveness
31%
Virus
15%
Virus Surveillance
33%
Virus-neutralizing Antibody
13%
Wales
55%
Western Europe
47%
WHO European Region
18%
World Health Organization
35%
Young Female
13%
Medicine and Dentistry
2009 H1N1 Influenza
11%
Antiviral Therapy
11%
Antivirus Agent
5%
Avian Influenza
11%
Case Fatality Rate
7%
COVID-19 Vaccine
13%
Cross Sectional Study
15%
Decision Making
14%
Disease Burden
8%
Disease Epidemiology
11%
Diseases
47%
Drug Uptake
11%
Group Structure
11%
Health Care
22%
Health Survey
11%
High Risk Population
12%
High-Risk Population
11%
Household
11%
Human Respiratory Syncytial Virus
47%
Infection
28%
Influenza A
11%
Influenza A (H1N1)
9%
Influenza A Virus (H1N1)
24%
Influenza A Virus (H3N2)
22%
Influenza Vaccination
8%
Influenza Vaccine
33%
Intensive Care
11%
Men Who Have Sex with Men
11%
Mortality Rate
14%
Mumps
11%
Pathogen
16%
Pertussis
11%
Pneumococcal Pneumonia
11%
Polymerase Chain Reaction
11%
Pontiac Fever
11%
Primary Health Care
20%
Public Health
18%
Reproductive Medicine
11%
Respiratory Disease
7%
Respiratory Tract Infection
29%
Returning Traveler
15%
Rotavirus
11%
Rotavirus Infection
11%
Seasonal Influenza
24%
Seasonal Variation
11%
Secondary Care
11%
Serotype
11%
Sex Worker
11%
Spatiotemporal Analysis
11%
Streptococcus Pneumonia
12%
Surveillance System
6%
Systematic Review
11%
Time Series Analysis
5%
Vaccine Efficacy
11%
Virus
9%
Virus Surveillance
33%